Paper9022011
Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
Wu C and 4 others. Eur J Immunol, 1997. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Papers, record 9022011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9022011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-12 | Major topic |
| Leukocytes, Mononuclear | Major topic |
| Receptors, Interleukin | Major topic |
| T-Lymphocytes | Major topic |
| CD28 Antigens | |
| CD3 Complex | |
| Cells, Cultured | |
| Humans | |
| Interferon-gamma | |
| Interleukin-10 | |
| Interleukin-4 | |
| Lymphocyte Activation | |
| Receptors, Interleukin-12 | |
| Signal Transduction | |
| Transforming Growth Factor beta |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41238404 | Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity. | MAbs | 2025 | https://conductscience.org/library/papers/41238404 | PubMed |
| 40211749 | Coordinated Regulation of Extrafollicular B Cell Responses by IL-12 and IFNγ. | Immunol Rev | 2025 | https://conductscience.org/library/papers/40211749 | PubMed |
| 31961868 | Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/31961868 | PubMed |
| 30995503 | The Immunobiology of the Interleukin-12 Family: Room for Discovery. | Immunity | 2019 | https://conductscience.org/library/papers/30995503 | PubMed |
| 24069393 | Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin? | PLoS One | 2013 | https://conductscience.org/library/papers/24069393 | PubMed |
| 23864330 | IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. | Hum Mutat | 2013 | https://conductscience.org/library/papers/23864330 | PubMed |
| 23509806 | CpG and interleukin-15 synergize to enhance IFN-γ production by activated CD8+ T cells. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23509806 | PubMed |
| 21198545 | The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21198545 | PubMed |
| 19067026 | Differential distribution of both IL-12Rbeta chains in the plasma membrane of human T cells. | J Membr Biol | 2009 | https://conductscience.org/library/papers/19067026 | PubMed |
| 16630024 | Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization. | Immunology | 2006 | https://conductscience.org/library/papers/16630024 | PubMed |
| 12941138 | Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activation. | Immunology | 2003 | https://conductscience.org/library/papers/12941138 | PubMed |
| 12836019 | The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. | Med Microbiol Immunol | 2004 | https://conductscience.org/library/papers/12836019 | PubMed |
| 11722650 | Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection. | Immunology | 2001 | https://conductscience.org/library/papers/11722650 | PubMed |
| 10455278 | IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10455278 | PubMed |
| 9918125 | IL-12 and viral infections. | Cytokine Growth Factor Rev | 1998 | https://conductscience.org/library/papers/9918125 | PubMed |
| 9673267 | Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. | Infect Immun | 1998 | https://conductscience.org/library/papers/9673267 | PubMed |
| 9502779 | Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9502779 | PubMed |
| 9336665 | Interleukin-12 in infectious diseases. | Clin Microbiol Rev | 1997 | https://conductscience.org/library/papers/9336665 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9022011
GET https://conductscience.org/api/papers/v1/9022011/authors